NDC 44206-452-91 - Hizentra
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44206-452
- Requested NDC
- 44206-452-91
- Package NDCs from labels
- 44206-452-91, 44206-452-02
- Manufacturer
- CSL Behring AG
- Effective date
- 2023-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hizentra - CSL Behring AG | CSL Behring AG | 2023-04-20 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44206-452-02 | Hizentra | 1 in 1 CARTON | LIQUID | 1 | 26 | |
| 44206-452-91 | Hizentra | 10 mL in 1 VIAL, SINGLE-DOSE | LIQUID | 10 | 26 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44206-452-02 | ML - Milliliter | 44206-452 | 13b617d5-9a55-442b-b1bb-da6640524602 | 1 | 2012-07-24 |
| 44206-452-91 | ML - Milliliter | 44206-452 | 755e8772-7f6d-46d3-a6a5-2bec24ac43c8 | 1 | 2017-03-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HUMAN IMMUNOGLOBULIN G | ACTIVE INGREDIENT | 66Y330CJHS | HIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG] | 13 | |
| Human immunoglobulin G | ACTIVE MOIETY | 66Y330CJHS | HIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG] | 13 | |
| HUMAN IMMUNOGLOBULIN A | INACTIVE INGREDIENT | 741C1PWQ88 | HIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG] | 13 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | HIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG] | 13 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | HIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cutaquig | IMMUNOGLOBULIN G | Octapharma USA Inc | f3de095f-791a-85dc-7a14-ec7790cb13aa | 2021-11-30 | Boxed warning, Warnings, Adverse reactions | 66Y330CJHS |
| CLINIMIX E | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE | Baxter Healthcare Company | 8469d6fb-d6ef-476f-8cc3-0905192de0a8 | 2021-04-13 | Warnings, Adverse reactions | 9DLQ4CIU6V |
| CLINIMIX | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE | Baxter Healthcare Corporation | dccff103-8695-400c-a15d-cc2fd078760a | 2021-04-13 | Warnings, Adverse reactions | 9DLQ4CIU6V |
| Travasol | LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE | Baxter Healthcare Corporation | 8543b5be-0f43-4891-9e56-d7c39fe839b5 | 2020-10-07 | Warnings, Adverse reactions | 9DLQ4CIU6V |
| ProSol | VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Baxter Healthcare Corporation | cc2ace81-5881-43f1-ba94-41b674adc2fc | 2020-10-07 | Warnings, Adverse reactions | 9DLQ4CIU6V |
| Clinisol | LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE | Baxter Healthcare Corporation | 65ffc962-7538-41ea-9afb-4af5fbce4c5b | 2014-06-13 | Warnings, Adverse reactions | 9DLQ4CIU6V |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.